Pneumeric, Inc. has formed a distribution agreement with JP Pharma to supply the Capnospot® Tension Pneumothorax Decompression Indicator in Brazil. The device allows quick, visual confirmation of correct needle placement, improving emergency medical care. Leaders from both companies expressed optimism about the partnership’s potential to save lives.
Pneumeric, Inc. has announced a partnership with JP Pharma to distribute Capnospot® Tension Pneumothorax Decompression Indicator in Brazil, enhancing emergency medical responses. This agreement allows police, military, and medical responders access to this critical life-saving device developed by Pneumeric.
The Capnospot® device, which utilizes color change for visual confirmation of correct needle placement, enables emergency personnel to administer vital treatments swiftly. JP Pharma’s position in the Brazilian medical market positions them well to introduce innovative medical technologies like Capnospot®.
Bruno Tavora, COO of JP Pharma, expressed excitement about the new collaboration, emphasizing their shared commitment to advancing pre-hospital care in Brazil, suggesting that together, they can significantly improve survival rates. Similarly, Deon Miller, CCO of Pneumeric, highlighted the potential for mutual benefits and successful market entry.
Capnospot® is crafted to enhance tension pneumothorax decompression accuracy, providing real-time confirmation that improves patient outcomes and supports first responders in critical situations.
Founded in 2021, Pneumeric, Inc. aims to enhance tension pneumothorax care, boasting FDA clearance and patents for their innovative Capnospot® technology. JP Pharma, established in 2008 by experienced professionals, is dedicated to providing Brazil with top-tier medical equipment through effective partnerships.
For further details regarding Pneumeric, Inc. and the Capnospot® device, visit their website. More information about JP Pharma is accessible on their official site as well.
Pneumeric, Inc.’s collaboration with JP Pharma marks a significant advancement in emergency medical technology available in Brazil. The introduction of the Capnospot® device aims to improve response effectiveness in treating tension pneumothorax, supporting emergency responders and enhancing patient care. Both companies are poised for a fruitful partnership that can lead to improved life-saving measures in Brazil.
Original Source: www.prweb.com
